An Open Label, Single Dose, Parallel Group Study to Evaluate Absorption and Transit Characteristics of TREXIMA and RELPAX in Patients Inside and Outside of an Acute Migraine Attack.
Phase of Trial: Phase III
Latest Information Update: 14 Feb 2018
At a glance
- Drugs Naproxen sodium/sumatriptan (Primary) ; Eletriptan
- Indications Migraine
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 23 Sep 2010 Trial phase changed from III to I as reported by ClinicalTrials.gov.
- 18 Sep 2008 New trial record.